Unknown

Dataset Information

0

De novo peptide grafting to a self-assembling nanocapsule yields a hepatocyte growth factor receptor agonist.


ABSTRACT: Lasso-grafting (LG) technology is a method for generating de novo biologics (neobiologics) by genetically implanting macrocyclic peptide pharmacophores, which are selected in vitro against a protein of interest, into loops of arbitrary protein scaffolds. In this study, we have generated a neo-capsid that potently binds the hepatocyte growth factor receptor MET by LG of anti-MET peptide pharmacophores into a circularly permuted variant of Aquifex aeolicus lumazine synthase (AaLS), a self-assembling protein nanocapsule. By virtue of displaying multiple-pharmacophores on its surface, the neo-capsid can induce dimerization (or multimerization) of MET, resulting in phosphorylation and endosomal internalization of the MET-capsid complex. This work demonstrates the potential of the LG technology as a synthetic biology approach for generating capsid-based neobiologics capable of activating signaling receptors.

SUBMITTER: Komatsu Y 

PROVIDER: S-EPMC8581506 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC6637945 | biostudies-literature
| S-EPMC7311176 | biostudies-literature
| S-EPMC4516494 | biostudies-literature
| S-EPMC2853261 | biostudies-literature
| S-EPMC4324449 | biostudies-literature
| S-EPMC7190706 | biostudies-literature
| S-EPMC10774119 | biostudies-literature
| S-EPMC7943567 | biostudies-literature
| S-EPMC6160918 | biostudies-literature
| S-EPMC3349770 | biostudies-literature